Provided By GlobeNewswire
Last update: Nov 25, 2024
MALVERN, Pa., Nov. 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, is pleased to announce a live investor webcast scheduled for December 11, 2024, at 4:30 PM EST.
Read more at globenewswire.com1.51
+0.04 (+2.72%)
Find more stocks in the Stock Screener
Curious about what's happening in today's session? Check out the latest stock movements and price changes.